相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Response to Letter: 'Reply to High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?'
M. Pineton de Chambrun et al.
JOURNAL OF INTERNAL MEDICINE (2021)
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful?
Simona Pascolini et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Autopsy findings in COVID-19-related deaths: a literature review
Aniello Maiese et al.
FORENSIC SCIENCE MEDICINE AND PATHOLOGY (2021)
Lupus anticoagulant in patients with COVID-19
Ariella Tvito et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)
Anti-β2GPI domain 1 antibodies stratify high risk of thrombosis and late pregnancy morbidity in a large cohort of Chinese patients with antiphospholipid syndrome
Tingting Liu et al.
THROMBOSIS RESEARCH (2020)
High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia
Carmine Gazzaruso et al.
CLINICAL RHEUMATOLOGY (2020)
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Julie Helms et al.
INTENSIVE CARE MEDICINE (2020)
Thromboinflammation and the hypercoagulability of COVID-19
Jean M. Connors et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
Mauro Panigada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Yan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Antiphospholipid Antibodies in Critically Ill Patients With COVID-19
Meng Xiao et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity
Daniel Bertin et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study
Siyuan Fan et al.
FRONTIERS IN NEUROLOGY (2020)
Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System
Seda Bilaloglu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19)
Morayma Reyes Gil et al.
JAMA NETWORK OPEN (2020)
Lupus anticoagulant is frequent in patients with Covid‐19: Response to Reply
Inès Harzallah et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
Katrien M. J. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19)
Xabier Gutierrez Lopez de Ocariz et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
Giulia Previtali et al.
THROMBOSIS RESEARCH (2020)
High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019
Emile Ferrari et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
Virginie Siguret et al.
THROMBOSIS RESEARCH (2020)
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19
Yu Zuo et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false-positive results?
Pieter M. M. De Kesel et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
EFFICACY AND SURVIVAL OF APREMILAST IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS IN REAL CLINICAL PRACTICE
I. Anon Onate et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats
Paolo Durigutto et al.
HAEMATOLOGICA (2019)
Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis
N. Abdel-Wahab et al.
LUPUS (2018)
Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β2-Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti-Domain 1 to Anti-Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome
Laura Andreoli et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Antiphospholipid antibodies in critically ill patients with cancer: A prospective cohort study
Juliana Vassalo et al.
JOURNAL OF CRITICAL CARE (2014)
Guidelines on the investigation and management of antiphospholipid syndrome
David Keeling et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Update of the guidelines for lupus anticoagulant detection
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Current concepts on the pathogenesis of the antiphospholipid syndrome
Bill Giannakopoulos et al.
BLOOD (2007)
Antiphospholipid antibodies and infections
RA Asherson et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
M Galli et al.
BLOOD (2003)
Viral infections and antiphospholipid antibodies
IW Uthman et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2002)
分享论文
